{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:24:32Z","timestamp":1782519872843,"version":"3.54.5"},"reference-count":29,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MHAA4549A is a human anti\u2010influenza A monoclonal antibody developed to treat influenza A. We report MHAA4549A serum, nasopharyngeal, and tracheal aspirate pharmacokinetics from a phase 2b study in hospitalized patients with severe influenza A. Patients were randomized 1:1:1 into 3 groups receiving single intravenous doses of 3600 mg (n = 55) or 8400 mg (n = 47) MHAA4549A or placebo (n = 56). Patients also received oral oseltamivir twice daily for \u22655 days. Serum, nasopharyngeal, and tracheal aspirate pharmacokinetic samples were collected on days 1\u201060 from MHAA4549A\u2010treated groups. Day 5 plasma samples from all groups were collected for assessing the pharmacokinetics of oseltamivir and its active metabolite, oseltamivir carboxylate. Noncompartmental pharmacokinetic analysis was performed using Phoenix WinNonlin. Data were collected during a preplanned interim analysis that became final when the trial terminated because of a lack of efficacy. Serum MHAA4549A concentrations were dose\u2010proportional and biphasic. Mean MHAA4549A clearance was 288\u2010350 mL\/day, and mean half\u2010life was 17.8\u201019.0 days. Nasopharyngeal MHAA4549A concentrations were non\u2010dose\u2010proportional. We detected MHAA4549A in tracheal aspirate samples, but intersubject variability was high. MHAA4549A serum and nasopharyngeal exposures were confirmed in all MHAA4549A\u2010treated patients. Serum MHAA4549A had faster clearance and a shorter half\u2010life in influenza A\u2010infected patients compared with healthy subjects. MHAA4549A detection in tracheal aspirate samples indicated exposure in the lower respiratory tract. Oseltamivir and oseltamivir carboxylate exposures were similar between MHAA4549A\u2010treated and placebo groups, suggesting a lack of MHAA4549A interference with oseltamivir pharmacokinetics.<\/jats:p>","DOI":"10.1002\/jcph.1652","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T12:08:40Z","timestamp":1593864520000},"page":"1509-1518","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection"],"prefix":"10.1002","volume":"60","author":[{"given":"Rong","family":"Deng","sequence":"first","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohong","family":"She","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Maia","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Lim","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melicent C.","family":"Peck","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"McBride","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Horn","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aide","family":"Castro","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"},{"name":"Present affiliation: Calico Life Sciences, LLC  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Newton","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Tavel","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Hanley","sequence":"additional","affiliation":[{"name":"Genentech, Inc  South San Francisco California USA"},{"name":"Present affiliation: Seattle Genetics  Bothell Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1333"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis211"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2059"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir648"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6625a3"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy874"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33293-2"},{"key":"e_1_2_11_9_1","unstructured":"World Health Organization. Influenza (Seasonal) fact sheet.https:\/\/web-prod.who.int\/entity\/csr\/resources\/publications\/surveillance\/WHO_CDS_CSR_ISR_99_2_EN\/en\/index.html. Updated November 6 2018. Accessed January 23 2019."},{"key":"e_1_2_11_10_1","unstructured":"Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases (NCIRD). Disease burden of influenza.https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html. Updated February 19 2019. Accessed September 16 2019."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.06.004"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005702"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.12.002"},{"key":"e_1_2_11_14_1","unstructured":"KamenL KhoE LinYL ChungS.Anti\u2010influenza antibody MHAA4549A induces ADCC in influenza\u2010infected cells. Poster presented at the Keystone Symposium Antibodies as Drugs (X2); March 6\u201010 2016;Whistler BC Canada."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00607-16"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-17"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0564-y"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1742"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00352-20"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00300-5"},{"key":"e_1_2_11_21_1","unstructured":"PatelK KirkpatrickC StrohM SmithP DengR.Population pharmacokinetic\/pharmacodynamic (PK\/PD) modeling of MHAA4549A an anti\u2010influenza A monoclonal antibody in healthy subjects challenged with influenza A virus. Poster presented at: 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting; September 17\u201021 2015; San Diego California.http:\/\/www.abstractsonline.com\/Plan\/ViewAbstract.aspx?sKey=066fe91c-1dff-48d2-a97e-9d682ce3a71c&cKey=e5865157-b5ac-4d2a-b813-d30a149af1e5&mKey=7a574a80-eab1-4b50-b343-4695df14907e. Accessed October 1 2016."},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1167294"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis636"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30435-0"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270012445206"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9631-6"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt201.21"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008329556"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22890"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1722"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.1652","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1652","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.1652","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T18:00:33Z","timestamp":1693936833000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.1652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1002\/jcph.1652"],"URL":"https:\/\/doi.org\/10.1002\/jcph.1652","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"2019-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}